Wednesday, Jan 29 2020 | Time 03:36 Hrs(IST)
image
  • Shah exhorts to resolve forest clearance, banking facility in each village
  • Chinese FM says China to enhance int'l cooperation over battle against epidemic
  • MPHC applies brakes on OBC quota
  • US peace deal for middle east aims to erase Palestine's national project : Hamas
  • MP CM to inaugurate Cargo Terminal
Science Technology


WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

Kolkata, Aug 30 (UNI) The World Health Organization (WHO) has revised its guidance on

contraceptive use to reflect new evidence that women at high risk of HIV can use any form

of reversible contraception, including progestogen-only injectables, implants and intrauterine

devices (IUDs), without an increased risk of HIV infection.

However, as these contraceptive methods do not protect against HIV and other sexually

transmitted infections (STIs), the guideline emphasizes that correct and consistent use of

condoms should be used where there is a risk of STIs, including HIV, a WHO media

statement here on Friday said.

WHO also recommends considering offering pre-exposure prophylaxis (PrEP) in settings

where the incidence of HIV is above 3 per cent, as appropriate.

The updated WHO guideline follows a thorough review of the latest scientific evidence.

It emphasizes that women should have access to the full range of modern contraceptive

methods so they can make informed choices around contraceptive choice and their sexual

health.

“Evidence shows that a woman’s risk of HIV should not restrict her contraceptive choice,”

said Dr Peter Salama, Executive Director, Universal Health Coverage/Life Course at WHO.

“All women should have access to a wide range of options for contraception as well as to

HIV prevention and to treatment if needed.”

The updated recommendations to the WHO guideline, Medical eligibility criteria for

contraceptive use, stem from a review of the latest evidence conducted by the independent

Guideline Development Group convened to inform WHO.

This Group assessed all of the evidence on hormonal contraception and risk of HIV

acquisition published since the previous review published in 2016, along with a systematic

review of all published evidence on copper-bearing IUDs and HIV risk.

The new evidence is largely based on the results of the Evidence for Contraceptive

Options and HIV Outcomes (or ECHO trial) - a randomized clinical trial that showed no

statistically significant differences in HIV acquisition among women using intramuscular

depot medroxyprogesterone acetate (DMPA-IM), copper IUDs, or levonorgestrel (LNG)

implants.

This new high-quality evidence supersedes the low to low-moderate quality evidence

from observational studies that had been previously available to inform WHO’s guidance.

The ECHO study – which was conducted across communities expected to have high

levels of HIV prevalence in Eswatini, Kenya, South Africa and Zambia - also revealed

concerningly high levels of HIV acquisition and other sexually transmitted infections (STIs)

among women seeking contraceptive services, particularly younger women, irrespective

of which of the three contraceptive methods they used.

“There is a clear need to ensure women in Africa have access to high quality HIV and

STI prevention and testing services, along with a wide range of contraceptive options to

suit their values, preferences, views and concerns,” said Dr Felicitas Zawaira, Director of

Family and Reproductive Health in WHO’s African region.

“In high HIV prevalence settings, these may include condom promotion, pre-exposure

prophylaxis (PrEP), as well as linkages to antiretroviral therapy for those testing HIV-positive,

and partner testing.”

MORE UNI BM SJC

More News
Coronavirus outbreak in China – What does it mean for Europe?

Coronavirus outbreak in China – What does it mean for Europe?

25 Jan 2020 | 1:58 PM

Copenhagen, Jan 25 (UNI) Following notification of pneumonia cases of unknown cause in Wuhan, China on December 31, 2019, a novel coronavirus (2019-nCoV) was identified as the cause by Chinese
authorities on January 7.

see more..
Identification of X-ray variability in Black hole binary systems

Identification of X-ray variability in Black hole binary systems

23 Jan 2020 | 4:05 PM

Kanpur, Jan 23 (UNI) A team of scientists from the Inter-University Centre for Astronomy and Astrophysics (IUCAA), Pune and the Indian Institute of Technology, Kanpur studied the X-ray emission from a well known black hole binary GRS 1915+105 using the Indian space Observatory AstroSat launched by ISRO.

see more..
Coronavirus: WHO extends emergency talks

Coronavirus: WHO extends emergency talks

23 Jan 2020 | 9:44 AM

Geneva, Jan 23 (UNI) The World Health Organization (WHO) on Wednesday night extended to Thursday its emergency talks on whether the novel coronavirus outbreak in China constitutes a Public Health Emergency of International Concern (PHEIC).

see more..
Health: Media dialogue in MP capital

Health: Media dialogue in MP capital

23 Jan 2020 | 9:43 AM

Bhopal, Jan 23 (UNI) The burden of non-communicable diseases including hypertension and diabetes is on the upward spiral in Madhya Pradesh, posing a threat to the physical and financial well-being of the residents.

see more..
Romania: Tuberculosis patients to avoid unnecessary hospitalisation

Romania: Tuberculosis patients to avoid unnecessary hospitalisation

22 Jan 2020 | 12:24 PM

Bucharest, Jan 22 (UNI) Romania’s Ministry of Health has launched a pilot project to conduct the treatment of tuberculosis (TB) patients in outpatient settings, thereby avoiding unnecessary hospitalisation.

see more..
image